Dalton Rodriguez
Nurse Practitioner · Nashville, TNNPI 1548537533
Payments from drug & device makers
Across 66 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$186
- Novo Nordisk$162
- Alnylam Pharmaceuticals Inc.$156
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$131
- Philips North America LLC$75
- Merck$71
- plus $552 from 16 others
What the payments were for
- Food & beverage$1,333100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $186 |
| Novo Nordisk | 8 | $162 |
| Alnylam Pharmaceuticals Inc. | 8 | $156 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $131 |
| Philips North America LLC | 4 | $75 |
| Merck | 5 | $71 |
| Amgen | 4 | $67 |
| Abiomed | 2 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Pfizer | 3 | $53 |
| Scpharmaceuticals Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Boston Scientific | 1 | $28 |
| Altathera Pharmaceuticals LLC | 2 | $25 |
| Novartis | 1 | $25 |
| Bayer | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Chiesi USA, Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
| AstraZeneca | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$138
How this compares
$1,333 in reported general payments places this provider in the 75th percentile of 2,662 nurse practitioner providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 63 | $87,042 |
| XareltoRivaroxaban | 26 | $31,917 |
| EntrestoSacubitril/Valsartan | 21 | $26,430 |
| Sildenafil Citrate | 11 | $7,152 |
| Amiodarone Hcl | 58 | $1,102 |
| Atorvastatin Calcium | 88 | $904 |
| Metoprolol Succinate | 60 | $848 |
| Valsartan | 25 | $721 |
| Carvedilol | 70 | $612 |
| Rosuvastatin Calcium | 19 | $569 |
| SotalolSotalol Hcl | 14 | $438 |
| ClopidogrelClopidogrel Bisulfate | 33 | $416 |
| Losartan Potassium | 24 | $408 |
| Amlodipine Besylate | 68 | $362 |
| Lisinopril | 48 | $337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $53 | $87,04263 claims |
| Johnson & JohnsonXarelto | $186 | $31,91726 claims |
| NovartisEntresto | $25 | $26,43021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Nashville
- Susan UtleyNashville$194K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Patricia MorrisNashville$53K
- Molly MueckeNashville$30K
- Cherish HoltNashville$20K
- Virginia BradshawNashville$17K
- Bettina EnghNashville$17K
- Megan HuningNashville$12K
- Amy HatcherMurfreesboro$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.